232 related articles for article (PubMed ID: 30614075)
21. Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters.
Wu W; Liu Y; Ye H; Li Z
Phytother Res; 2018 Dec; 32(12):2428-2435. PubMed ID: 30123958
[TBL] [Abstract][Full Text] [Related]
22. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.
Jiang P; Wu X; Wang X; Huang W; Feng Q
Oncotarget; 2016 Jul; 7(28):43337-43351. PubMed ID: 27270317
[TBL] [Abstract][Full Text] [Related]
23. Revisiting the substrate specificity of mammalian α1,6-fucosyltransferase reveals that it catalyzes core fucosylation of
Yang Q; Zhang R; Cai H; Wang LX
J Biol Chem; 2017 Sep; 292(36):14796-14803. PubMed ID: 28729420
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.
Han X; Chen H; Zhou J; Steed H; Postovit LM; Fu Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30049957
[TBL] [Abstract][Full Text] [Related]
25. FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer.
Bastian K; Scott E; Elliott DJ; Munkley J
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466384
[TBL] [Abstract][Full Text] [Related]
26. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
Ivy KD; Kaplan JH
Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
[TBL] [Abstract][Full Text] [Related]
27. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling.
Wang X; Gu J; Ihara H; Miyoshi E; Honke K; Taniguchi N
J Biol Chem; 2006 Feb; 281(5):2572-7. PubMed ID: 16316986
[TBL] [Abstract][Full Text] [Related]
28. Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans.
Yang Q; Wang LX
J Biol Chem; 2016 May; 291(21):11064-71. PubMed ID: 27008861
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of α1,6-fucosyltransferase promotes neuroinflammation by increasing the sensitivity of glial cells to inflammatory mediators.
Lu X; Zhang D; Shoji H; Duan C; Zhang G; Isaji T; Wang Y; Fukuda T; Gu J
Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):598-608. PubMed ID: 30572004
[TBL] [Abstract][Full Text] [Related]
30. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
[TBL] [Abstract][Full Text] [Related]
31. Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability.
Ali AY; Kim JY; Pelletier JF; Vanderhyden BC; Bachvarov DR; Tsang BK
Mol Carcinog; 2015 Nov; 54(11):1301-14. PubMed ID: 25154814
[TBL] [Abstract][Full Text] [Related]
32. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin.
Safaei R; Maktabi MH; Blair BG; Larson CA; Howell SB
J Inorg Biochem; 2009 Mar; 103(3):333-41. PubMed ID: 19124158
[TBL] [Abstract][Full Text] [Related]
33. ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression.
Wu G; Peng H; Tang M; Yang M; Wang J; Hu Y; Li Z; Li J; Li Z; Song L
EBioMedicine; 2021 Sep; 71():103558. PubMed ID: 34521054
[TBL] [Abstract][Full Text] [Related]
34. Distinctive domains and activity regulation of core fucosylation enzyme FUT8.
Tomida S; Nagae M; Kizuka Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130561. PubMed ID: 38218458
[TBL] [Abstract][Full Text] [Related]
35. Decreased core-fucosylation contributes to malignancy in gastric cancer.
Zhao YP; Xu XY; Fang M; Wang H; You Q; Yi CH; Ji J; Gu X; Zhou PT; Cheng C; Gao CF
PLoS One; 2014; 9(4):e94536. PubMed ID: 24732908
[TBL] [Abstract][Full Text] [Related]
36. Inhibiting post-translational core fucosylation prevents vascular calcification in the model of uremia.
Wen X; Liu A; Yu C; Wang L; Zhou M; Wang N; Fang M; Wang W; Lin H
Int J Biochem Cell Biol; 2016 Oct; 79():69-79. PubMed ID: 27521658
[TBL] [Abstract][Full Text] [Related]
37. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
38. The role of FUT8-catalyzed core fucosylation in Alzheimer's amyloid-β oligomer-induced activation of human microglia.
Jin LW; di Lucente J; Ruiz Mendiola U; Tang X; Zivkovic AM; Lebrilla CB; Maezawa I
Glia; 2023 May; 71(5):1346-1359. PubMed ID: 36692036
[TBL] [Abstract][Full Text] [Related]
39. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
[TBL] [Abstract][Full Text] [Related]
40. Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid-cisplatin-based liposomes.
Song J; Ren W; Xu T; Zhang Y; Guo H; Zhu S; Yang L
Drug Des Devel Ther; 2017; 11():441-449. PubMed ID: 28255230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
